SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patien...
Leadership
David Gonzalez Angulo M.D.
CEO, President & Director
Ivor Macleod CPA, M.B.A.
Chief Financial Officer
Scott Sukenick J.D.
Chief Legal Officer & Corporate Secretary
Daniella Gigante
Vice President of Human Resources & Information Technology
